CD40LG and systemic lupus erythematosus: Many studies have found increased serum or plasma levels of soluble CD40L (sCD40L) in patients suffering from systemic lupus erythematosus (SLE), Sjögren’s syndrome (SS), inflammatory bowel disease (IBD), and cardiovascular disease (112–117).